Spyridon Papapetropoulos Lipocine Inc. (LPCN) insider trading activity

LPCN Quotes by TradingView

Spyridon Papapetropoulos is Director of Lipocine Inc.. Currently has a direct ownership of 21,739 shares of LPCN, which is worth approximately $105,868. The most recent transaction as insider was on Nov 22, 2022, when has been sold 21,739 shares (Common Stock) at a price of $0.47 per share, resulting in proceeds of $10,217. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.7K
0% 3M change
0% 12M change
Total Value Held $105,868

Spyridon Papapetropoulos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2022
BUY
Open market or private purchase
$10,217 $0.47 p/Share
21,739 Added 50.0%
21,739 Common Stock

Also insider at

VIGL
Vigil Neuroscience, Inc. Healthcare
Chief Medical Officer
SP

Spyridon Papapetropoulos

Director
Cambridge, MA

Track Institutional and Insider Activities on LPCN

Follow Lipocine Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LPCN shares.

Notify only if

Insider Trading

Get notified when an Lipocine Inc. insider buys or sells LPCN shares.

Notify only if

News

Receive news related to Lipocine Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LPCN